MOTS, US62014P5044

Motus GI stock closed at USD 0.0002 after Chapter 11 sale

Published on 10/04/2026 at 20:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Motus GI stock traded 250 shares on October 2, 2026, after a Chapter 11 asset sale reshaped the listed shell. Pure-Vu remains the company website's core product.

MOTS, US62014P5044, Illustration mit AI erstellt.

Motus GI Holdings, Inc. (ISIN US62014P5044) closed at USD 0.0002 on OTC Markets OTCPK on October 2, 2026, with 250 shares traded. The stock's central story is now the transition from a medical-device operator to a listed shell following a Chapter 11 asset sale.

Chapter 11 changed the equity story

According to ARIVA, Motus GI entered Chapter 11 proceedings in 2024 and sold substantial assets to a buyer. The profile describes the listed company as a shell whose remaining role is tied to winding down corporate matters.

That transaction separates the quoted security from the former operating model. The previous business focused on Pure-Vu, an endoscopy system designed to improve visualization during colonoscopy procedures, while the technology's future depends on the asset buyer.

Pure-Vu remains the product anchor

Motus GI's website presents Pure-Vu as a system for endoscopy and colonoscopy procedures and highlights a 38% to 96% improvement in visualization following use, linking the product to the company's earlier clinical and commercial strategy.

The contrast is material for shareholders: the product page describes a medical-device technology platform, while the company profile describes a listed entity shaped by the 2024 restructuring and asset transfer. The October 2 trading record adds a market measure to that corporate backdrop, with 250 shares changing hands at the USD 0.0002 close.

Motus GI stock stays at USD 0.0002

Motus GI stock closed at USD 0.0002 on October 2, 2026, on OTC Markets OTCPK. The session's reported change was 0.00%, making the restructuring history and the status of the Pure-Vu assets more relevant to the stock narrative than a daily price move.